The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/appi.ps.202000177

Abstract

Researchers increasingly recognize that stakeholder involvement enhances research relevance and validity. However, reports of patient engagement in research that relies on administrative records data are rare. The authors’ collaborative project combined quantitative and qualitative studies of costs and access to care among U.S. adults with employer-sponsored insurance. The authors analyzed insurance claims to estimate the impacts on enrollee costs and utilization after patients with bipolar disorder were switched from traditional coverage to high-deductible health plans. In parallel, in-depth interviews explored people’s experiences accessing treatment for bipolar disorder. Academic investigators on the research team partnered with the Depression and Bipolar Support Alliance (DBSA), a national advocacy organization for people with mood disorders. Detailed personal stories from DBSA-recruited volunteers informed and complemented the claims analyses. Several DBSA audience forums and a stakeholder advisor panel contributed regular feedback on study issues. These multiple engagement modes drew inputs of varying intensity from diverse community segments. Efforts to include new voices must acknowledge individuals’ distinct interests and barriers to research participation. Strong engagement leadership roles ensure productive communication between researchers and stakeholders. The involvement of people with direct experience of care is especially necessary in research that uses secondary data. Longitudinal, adaptable partnerships enable colearning and higher-quality research that captures the manifold dimensions of patient experiences.

HIGHLIGHTS

  • Patient stakeholder involvement improves research but is rarely reported in studies based on administrative data.

  • The authors enriched a large quantitative study aimed at estimating the effects of insurance benefit changes on individuals with bipolar disorder with a qualitative interview study and multiple layers of patient engagement.

  • A longitudinal, flexible partnership between academic researchers and advocacy leaders expands our understanding of patients’ experiences accessing behavioral health care.

The involvement of patients and other stakeholders across all stages of health-related research is now a broadly recognized priority (16). For example, stakeholder inputs before project conception help ensure that research questions align closely with the concerns of people directly affected by a given condition or care practice. Incorporating the expertise, lived experience, and social connections of stakeholders improves key study elements such as instrument design or participant retention. Thorough interpretation of results requires diverse perspectives. When relevant patients, providers, and administrators are involved in decisions about how study findings are disseminated, the reach of the findings is broadened, and their implementation may occur sooner. Engagement demonstrates respect for the people affected and advances the goal of high-quality research. Accordingly, the U.S. Patient-Centered Outcomes Research Institute (PCORI) (1, 2) and multiple other private and government sponsors, most explicitly the United Kingdom’s National Institute for Health Research (7, 8), now insist on stakeholder involvement in the research process.

Patient engagement may highlight and help overcome particular challenges within research on mental health care, such as inadequate integration with other medical care, marginalized communities, disrupted connections between patients and health systems, and the divergence between traditional patient outcomes in psychiatric research (e.g., symptoms and hospitalizations) and outcomes that patients identify as especially important (e.g., quality of life and a sense of identity) (914). Indeed, the origins of the broad movement toward patient-involved and even patient-led research lie in the stigmatization, patronization, and neglect experienced by key communities of patients (e.g., those living with HIV, mental illness, or disability) who were predominantly outside of traditional medical power structures and became motivated to reform the practice of research (8, 15).

It can be difficult to characterize current engagement in health research through a review of the research literature because approaches, settings, and terminologies vary so widely, and researchers often report only their study findings without providing the details of the underlying engagement processes (16, 17). The literature includes prominent examples of patient-involved prospective surveys and projects aimed at developing research agendas (1820). Many other reports of research with significant stakeholder engagement are either randomized controlled trials or qualitative studies focused on specific clinical questions. These studies are typically conducted in local clinical settings and engage with patients and other stakeholders from those settings (9, 2125). Some focused clinical studies have leveraged partnerships with national patient advocacy organizations (13, 2628). Patient engagement has not been prominently reported in research that relies on large health system databases. The potential for greater patient involvement in this type of research is currently developing in “patient-powered research networks” that make use of web-based communication and data collection technologies (2931), but reports from completed projects are scant. Our review of the current literature has revealed a paucity of published reports of patient engagement in retrospective studies using health system data and focusing on broader policy concerns such as insurance design or access to care.

This article presents an example of quantitative health systems research that uses large-scale administrative data and incorporates major patient stakeholder engagement. Our project studied the impact of different commercial health insurance arrangements in the United States on outcomes for individuals living with bipolar disorder and how people with this condition cope with the costs of care. Here, we explain how different engagement components fit into our project and furthered its central goal of improving our understanding of the effects of insurance benefit design on access to behavioral health care. Our engagement approach and experience may inform future research collaborations. The detailed research results of this project are published elsewhere (3236).

Research Context

Our project investigated health insurance design, focused on individuals with bipolar disorder, and combined two distinct quantitative and qualitative studies. For the quantitative study, we used a national database of commercial health insurance claims to evaluate how a change from a low-deductible insurance plan to a high-deductible plan affects care and costs for people with bipolar disorder (32). High-deductible health plans (HDHPs) require plan members to pay 100% of the costs for many services at the beginning of each year, until the deductible threshold (e.g., $2,500) has been reached. Once the deductible is reached, “traditional”-type coverage begins, with members paying copayments or coinsurance for most services. HDHPs usually have lower monthly premiums than traditional plans but require more patient cost-sharing for services received, posing a barrier to care for some people and shifting costs onto sicker individuals, who require more care.

We identified individuals with bipolar disorder through diagnosis codes in anonymized claims data. We created two cohorts on the basis of specific employers and whether these employers either kept all their covered employees in a traditional, low- or no-deductible plan for at least 2 years or switched all their employees from a traditional plan to an HDHP in the second year. In a retrospective, quasi-experimental design, we compared outcomes after the switch into HDHPs for matched enrollees between the two cohorts. We measured changes in routine mental health services use, acute services use, and patient out-of-pocket costs. Our research questions are summarized in Box 1. The aims of the quantitative study were to estimate increases in cost burden for HDHP enrollees and to determine whether people responded to higher costs by changing their utilization of care.

Box 1. Summary of research questions for the project

Quantitative Study

Study population and design
  • Nationwide commercial insurance claims data set

  • Members with bipolar disorder and 2 years of continuous employer group enrollment (2003–2014; N=22,500)

  • Intervention group experienced an employer-mandated switch from a traditional plan to a high-deductible plan after year 1

  • A matched control group remained in a traditional plan in both years

  • Interrupted time series and difference-in-difference analyses

Research questions
  • • Comparing before and after the switch, how did switching to a high-deductible health plan affect patient outcomes?

  •  ○ Number of outpatient visits: psychiatrist, nonpsychiatrist mental health provider, or other mental health-related provider

  •  ○ Out-of-pocket costs per visit and annual total

  •  ○ Standardized doses of medications recommended for bipolar disorder treatment

  •  ○ Other medications: psychiatric and nonpsychiatric

  •  ○ Out-of-pocket costs for medications

  •  ○ Receipt of recommended blood tests, for those taking specific medications for bipolar disorder

  •  ○ Number of emergency department visits and hospital admissions: psychiatric and nonpsychiatric

  •  ○ Out-of-pocket costs for hospital-based care

Qualitative Study

Study population and design
  • Volunteers recruited nationwide through local chapters of Depression and Bipolar Support Alliance

  • Individuals with bipolar disorder and employer-sponsored insurance (N=28)

  • Family caregivers for such an individual (N=12)

  • In-depth telephone interviews, recorded and transcribed

Research questions
  • Current treatments for bipolar disorder and other conditions

  • Satisfaction with care

  • Out-of-pocket costs for care

  • Ability to afford care, cost-related underuse

  • Insurance coverage, premiums, benefit design, plan provider network

  • Understandability of insurance and ease of navigation

  • Who helps in navigating care?

  • Other strategies for wellness

  • Priorities among types of care and decision-making process

In a parallel qualitative study, we conducted in-depth interviews focused on people living with bipolar disorder and using employer-sponsored coverage, including commercial plans of diverse types (33). We explored respondents’ experiences navigating the health care system and making choices about care in the context of their cost-sharing requirements (Box 1).

These two halves of our mixed-methods investigation were meant to inform each other throughout the 3-year project period, with interviews probing and revealing phenomena not readily observable in claims data. The overarching research design could be described as “concurrent triangulation,” with equal priority placed on the quantitative and qualitative elements (37). The academic collaborators on the core team had extensive experience in using quantitative methods to study effects of HDHPs generally and of insurance coverage design for populations with serious mental illness (3850). We incorporated the qualitative study and an array of stakeholder engagement components into this project to enhance its depth, comprehensiveness, interpretation, and impact.

Engagement Components and Protocol

The project had four major engagement components (see diagram in an online supplement to this article): core team members experienced with bipolar disorder, a stakeholder advisor panel that met quarterly, the in-depth interview study, and outreach via social media and e-mail to communities affected by bipolar disorder. The interview study occupied a unique position, simultaneously representing research activity and engagement.

The lynchpin of our engagement with people living with bipolar disorder was the partnership between academic researchers and the Depression and Bipolar Support Alliance (DBSA), a large national nonprofit organization focused on mood disorders (51, 52). DBSA is distinctive for its focus on advocacy, local support groups, wellness, and online tools and information and is led primarily by “peers”—that is, individuals with mood disorders—and their family members. The term “peers” is preferred in the community over “patients,” which is unsuitable for individuals not in formal treatment and too limited to describe even people who are in treatment. “Peer” better conveys a person in full. An executive officer of DBSA (P.M.F.) served as coinvestigator on our core research team, contributing to all research activities and coleading the interview study and community engagement.

Although the project’s engagement with DBSA peers and family members is the focus of this article, our stakeholder engagement more broadly included psychiatrists and individuals representing health care delivery systems, insurers, and employers. Box 2 summarizes the backgrounds of our core research team and stakeholder advisor panel. Members of both bodies had substantial technical expertise and often wore more than one hat. Most were present during protocol development, before application for funding.

Box 2. Backgrounds of the members of the core study team and stakeholder advisor panela

Investigators

  • Health systems researcher/primary care physician

  • Health systems researcher/pharmacologist

  • Health systems researcher/psychiatrist

  • Health systems researcher/family member

  • Two health systems researchers

  • Statistician

  • Advocacy professional/family memberb

Staff

  • Project manager

  • Grant manager

  • Two programmer analysts

  • Qualitative interviewer and analyst

Stakeholder Advisors

  • Individual peer/insurance professionalb

  • Family member/insurance professionalc

  • Family member/lawyer/historianb

  • Insurance professional/health systems researcherc

  • Employer representative/insurance professionalb,c

  • Psychiatrist/health systems researcherb

  • Psychiatrist/insurance professionalc

  • Psychiatrist/advocacy professional

a Investigators and staff received salary support. Advisors were offered an annual honorarium ($500), but most declined, citing their employers’ rules. One advisor was a paid consultant to the project with no honorarium.

b Affiliated with the Depression and Bipolar Support Alliance.

c Joined project after funding application.

Our DBSA coinvestigator led recruitment for the in-depth interviews, including distribution of flyers to leaders of all the approximately 300 local DBSA chapters in the United States. Volunteers contacted her for preliminary screening. Then, an interviewer based in an academic setting carried out the secondary screen, obtained informed consent, and conducted 1-hour interviews. Respondents were individuals with bipolar disorder or family members involved in their care. Following a semistructured guide, the interviews explored domains such as the types of care people used, costs, affordability, and priorities for care (Box 1). The interview guide was jointly drafted by two academics and the DBSA coinvestigator.

We conducted community outreach and feedback exclusively through DBSA channels approximately quarterly over 3 project years. Our protocol called for selecting topics on a rolling basis to fit project needs as they developed. For example, we envisioned seeking at various times further insights into care for bipolar disorder and how people manage it, community interpretations of and interest in preliminary findings, and the most effective ways of presenting results. DBSA offered multiple avenues for reaching people with personal experience or professional knowledge of bipolar disorder, including DBSA’s Facebook page, the “Care for Your Mind” blog (53), local DBSA chapters, a network of regional affiliate advocacy organizations, and DBSA’s longstanding Peer Council.

Our engagement approach was shaped mainly by the PCORI Engagement Rubric (54). PCORI requires that sponsored research questions be patient-centered (informed and endorsed by patients) and that patients and other key stakeholders be meaningfully involved. Although PCORI’s Rubric was strongly influenced by the community-based participatory research (CBPR) (12, 15) movement that rose to prominence in the decades before PCORI’s establishment, the two frameworks are not interchangeable. CBPR emphasizes equitable sharing of research roles among partners and stresses results that advance social justice and eliminate disparities. PCORI emphasizes comparative effectiveness and generating information to support better decision making in health care. In addition, CBPR is especially focused on the patient or service user, whereas PCORI presses for involvement by multiple categories of stakeholders and decision makers, including family members, clinicians, and health system administrators. PCORI welcomes the use of CBPR strategies in the research it funds but is flexible on what engagement may look like, and a wide range of projects and pathways have emerged (1, 8, 55, 56). Our approach aligns with each distinct principle of CBPR (e.g., mutual benefit, empowerment, and sharing of information) (12, 15) to an extent, but not with the across-the-board rigor that would earn the CBPR label.

Engagement as Experienced

Investigators

The project benefited from fast friendship between the academic and advocacy coleads on the interview study and community engagement (J.M.M. and P.M.F.). Extensive telephone, e-mail, and face-to-face communications fostered intensive colearning, whereby each colead developed an understanding of the other’s professional world, norms, and language. For example, the DBSA coinvestigator received formal training in the protection of human subjects, and we shared thoughts on how institutional review board requirements for health-related research contrast with the freedom DBSA typically enjoys as an advocacy organization gathering and reporting information about its audience. We discussed other relevant projects under way, eventually forging new collaborations. Early in the current project, the academic colead urged recruiting interviewees from a defined population—DBSA chapters—while expressing skepticism of web-based platforms that the DBSA colead felt would accelerate recruitment. The academic colead felt that a single recruitment avenue offered clarity in later reporting and confidence that interviewees had “authentic” roots in DBSA. We adhered to that decision, but, over time, the authenticity of the DBSA Facebook audience became increasingly obvious, and slow chapter-based recruitment became a concern. On best specific strategies for outreach to chapters and Facebook readers, DBSA consistently charted the course. Outreaches were crafted, and their resulting feedback was analyzed jointly by the two coleads.

The academic colead acted as liaison between qualitative and quantitative project activities because it was not feasible for all investigators to fully immerse themselves in both. Nevertheless, all investigators attended monthly project meetings, contributing to protocol refinements for both studies. Our DBSA coinvestigator brought contemporary issues into these discussions, such as the growing role of paid peer counselors and the distinction between “getting to wellness” and merely eliminating clinical symptoms. Although the term “patient” is prominent in publications about health care and its costs and research engagement, many DBSA peers consider the word too narrow and disempowering, so our investigators learned to seek alternatives. The DBSA coinvestigator, in turn, reviewed our progress with DBSA’s peer-led national headquarters throughout the project period.

Stakeholder Advisor Panel

Quarterly meetings brought together the stakeholder advisors and the full research team. Investigators reviewed recent study results and community feedback, upcoming plans, and any problems or pending decisions. The meetings were opportunities to take stock of the project and receive fresh perspectives and ideas. All attendees had substantial content expertise, and the moderate size of the group permitted discussions that were simultaneously high-level, informal, and generally satisfying. Nevertheless, after a year, in response to a peer representative’s concerns, we revised our meeting format. The academic researchers had come to panel meetings having greater familiarity with both the project and the other attendees but having little experience with engaged research. In their diligence, researchers sometimes inadvertently dominated discussions, and some peer representatives felt unheard. Recognition of this problem was slow because most attendance was by telephone. To rebalance the meetings and elevate peer voices, we adjusted our procedures as follows: helping external advisors feel readier to contribute by distributing slide decks further in advance, with slides explicitly labeled “questions for our advisors,” and establishing a hierarchical speaking order for discussion periods. We invited comments first from peer representatives, next from other external advisors, and then from researchers. Participants agreed that the discussion quality improved as a result of these changes.

Most research team members were unable to extensively examine interview transcripts or comments gathered through social media, so quarterly meetings were their primary engagement experience. Peer representatives on the advisor panel offered interpretations of study results through the lens of personal experience, suggested which results would be useful for peer audiences, and highlighted health care system dysfunctions deserving closer study. The liaison investigator encouraged follow-up comments and conversations after these meetings, which were frequent and fruitful and strengthened feelings of trust.

In-Depth Interview Study

The in-depth interviews had high value within the project both as a formal research aim and activity and as a way to incorporate more peer voice and experience into the project generally. Our claims data came from a single large insurer, and our quantitative study cohorts were highly specified. By contrast, interview respondents reported a range of coverage situations—all were employer sponsored, but with different years’ duration, levels of generosity, and benefit structures. Respondents shared details of their living circumstances and journeys toward recovery and provided fully dimensional views of their experience navigating systems of care for bipolar disorder. They heightened our awareness of issues such as the U.S. psychiatrist shortage, narrow provider networks, self-coordination between primary and behavioral care, disruptions in care following routine changes in employer benefits, mental illness stigma, complications of psychotropic treatment, and strategies for achieving wellness and reducing costs. Insights from the interviews guided analyses of the claims data. For example, stronger awareness of network-related problems led us to examine regional differences more closely and develop plans for detecting evidence of care that is obtained entirely outside of coverage.

Our claims data analyses detected only modest effects on care utilization following the shift into HDHPs, despite substantial increases in cost-sharing. Specifically, we observed evidence of cost-driven reductions in psychotherapy visits but not in psychiatrist visits or medications. These modest findings were more easily understood in light of our interview findings. Respondents reported great reluctance to tinker with their mental health care if it was working; many explained that when money was tight, they usually tried to cut back in other areas, to the point of genuine hardship, but not their care for bipolar disorder (33). Conducting interviews thus augmented our project by informing and improving empirical analyses and extending beyond them with distinct findings. Having a mixed-method research design can hedge against the disappointment of “null” statistical results. Interviews seldom produce null results, because their purpose is to unearth what people experience and say, and they almost always yield some insight or finding. Moreover, by illustrating the trade-offs and hardships in daily life that often stem from high costs of care, the interviews revealed consequences of high costs that were not detectable in claims data. This strengthened our net findings and increased the likelihood that policy makers consuming the research might consider reforms to protect patients from such harms.

The interviews were also deeply moving: people told vivid, intimate stories with granularity and humor. They humanized our research questions in ways that claims data cannot, sharpening our sense of the project’s potential impact. The interviews effectively created another community of clients for our research, reminding us of its importance and the need to do it well.

Community Outreach and Feedback

We periodically reflected on what aspects of the project would be clarified with more real-world examples or would be augmented by fresh perspectives; we formulated these into questions for DBSA’s audience. These outreach-and-feedback activities overlapped in purpose with our interview study in that we received many additional stories and insights gained through lived experience, adding to our research ideas, understanding, and motivation.

However, in the research realm, engagement feedback is classified very differently from study data (i.e., interviews and claims data). We could learn from these comments and analyze and summarize them but could never publish studies from them; they remained for internal use only and were not monitored under standard human subject protections. Also, feedback comments were not collected with the same rigor as the study data. Questions could be changed at the last minute on Facebook and the blog website, and anyone on the Internet could respond. Small sample sizes were not cause for concern. For researchers, this flexibility felt liberating. We floated open-ended questions and structured capsule surveys of varying lengths and topics (Table 1). Over time, we stopped targeting the questions solely to people with employer-sponsored insurance. Instead, we asked audience members to indicate their coverage situation and then examined whether their responses were consistent across different coverage types. Also, by the middle of the project, all social media outreaches used a capsule survey design. Each outreach presented about a dozen questions with a mixed format—typically, a multiple-choice item, followed by an invitation to tell us more in an open-response item. The multiple-choice format allowed audience members to respond quickly by using a cell phone if that was their preference. Although the feedback did not offer formal empirical validation of our study data, it provided us with “gut checks.” Community comments also generated hypotheses for potential exploration in future research (e.g., on the positive and negative aspects of employment for wellness or on cost conversations with providers).

TABLE 1. Summary of community outreach and feedback topics by study yeara

Outreach topicPlatformNo. of responses
Year 1
 Current trends in cost-sharing arrangements in employer plansCare for Your Mind (CFYM) blog30
 Is it important to study high-deductible health plans (HDHPs) and, if so, why?
 Vulnerable populations: what are particular challenges facing individuals who are younger, in rural areas, or have other illnesses?CFYM blog24
 Experiences of availability and accessibility of in-network psychiatristsAdvocacy Network43
 Do you see a psychiatrist? Do you see a therapist? How are these visits paid for?Chapter newsletter13
Facebook0b
Year 2
 Reasons for delaying a mental health visitAdvocacy Network63
 Consequences of delaying a mental health visit
 Exploring and understanding seven issues arising from the in-depth interviewsPeer Council30
  Health problems related to bipolar disorder
  Financial problems related to bipolar disorder
  Ambiguous interview responses about affordability
  Impact of deductible across course of year
  Drug manufacturer discounts
  Disruptions in care due to changes in insurance
  Differences in practice in private versus community mental health clinic-based care
 Acute care: experiences of its use, accessibility, role, and importanceFacebook96
 Effectiveness of and practical concerns around psychiatric hospitalizations, partial hospitalization, and intensive outpatient programsPeer Council8
 Being employed and living with bipolar disorder: positive and negative experiences and decisions facedFacebook202c
Year 3
 Results from our quantitative study on HDHPs and mental health outpatient visits: surprising, interesting, impactful?Facebook0b
Advocacy Network9
 Generalizability vs. possible biases in our in-depth interview samplePeer Council3
 To what extent do psychiatrists and therapists coordinate care?Facebook33
 Likely response to a hypothetical increase in out-of-pocket costs
 Blood lab monitoring: how are tests arranged and provided; any barriers?Peer Council5
 Patient-provider communication around out-of-pocket costsFacebook115
 Summary findings to date: do they resonate?Peer Council3

aCare for Your Mind (53) blog and Depression and Bipolar Support Alliance (DBSA) Facebook feedback opportunities were presented on their websites as call-out questions linking to a structured capsule survey on a separate web page. Outreaches to the DBSA Advocacy Network, DBSA chapter leaders, and DBSA Peer Council were conducted via e-mails sent to group lists, and reply e-mails were captured. All outreaches included some introductory text referring to our research project, followed by specific questions.

bTechnical errors resulted in a nonresponse.

cThis Facebook post linked to a brief capsule survey, but because of a formatting error, many people responded directly via their own Facebook posts, and some of those responses were not captured.

TABLE 1. Summary of community outreach and feedback topics by study yeara

Enlarge table

Outreaches to the DBSA Peer Council or DBSA Advocacy Network were an excellent complement to DBSA’s social media presence, which is estimated to reach millions of individuals. Compared with the social media activities, these outreach efforts reached smaller numbers of individuals (about 300 and 2,500, respectively), identifiable to and having enduring relationships with DBSA. They included a higher proportion of people with professional experience of bipolar disorder (e.g., clinicians). Because they received multiple e-mails over time about our project, most people in these two groups had longitudinal familiarity with it. Peer Council and Advocacy Network outreaches thus fell somewhere on a continuum between the queries for the vast DBSA Facebook audience and for our intimate stakeholder advisor panel. Because we used e-mail to contact these two groups, we tried to limit the burden (i.e., frequency and length) of contacts and selected questions taking advantage of the deeper DBSA involvement of these groups. That said, even for Facebook- and blog-based outreaches, we felt that four per year was a prudent maximum to avoid audience fatigue with our project and interference with other DBSA priorities for community interaction.

Response tallies ranged from zero to several hundred per outreach, likely reflecting several factors, including which platform was used, level of interest in specific topics, whether people felt they could comment productively, occasional technical glitches, and fluctuations in competing demands for audience attention. We struggled more than anticipated to generate feedback about our project or its results. Response volume was greater when we asked for people’s own experiences. Negative reactions were rare (e.g., someone pointing to the role of academic experts in creating prominent problems in U.S. health care). Instead, we were encouraged by frequent, unsolicited “cheerleading” comments about the importance of research that involves peers and shines light on issues like health care affordability.

Dissemination of and engagement around our actual findings are ongoing; plans include joint appearances at scientific conferences and posting links to articles and lay synopses on DBSA platforms. Solid stakeholder involvement throughout a project ensures that there will be multiple partners at the project’s end who are excited to spread its messages and help identify potential opportunities for translation into practice.

Discussion and Conclusions

Health services research using secondary administrative data is increasingly common, as is patient-centered or patient-engaged research, yet reports of projects bridging administrative data and patient engagement have been rare. Our research examined the use and affordability of health services among people who have bipolar disorder and obtain health care through employer-based insurance. To support its success, we built in layers of stakeholder engagement. In a fairly traditional way, we strengthened our understanding of the subject matter by involving technical experts in psychiatry, health care delivery, insurance, and employer oversight of health benefits. More novel for our research team and for health services research that relies on retrospective data sources was the involvement of individuals with lived experience of bipolar disorder; this engagement was multipronged, longitudinal, and dynamic. DBSA, as a major national advocacy group with sophisticated operations already focused on similar topics, was an invaluable partner for this project. DBSA had the ability to open multiple avenues of essential engagement promptly and professionally. Our project engaged peers and their family members before, during, and after the project, as coinvestigator, advisor panel members, in-depth interview subjects, and ad hoc commenters. Having a variety of engagement components was itself beneficial, allowing hundreds of peer stakeholders to contribute to our project according to their levels of interest, ability, and engagement with DBSA. This variety yielded both range and depth in additional perspectives.

We met a goal of fostering engagement that was “more than token” (7, 57) and affected the research and everyone involved in it. Career researchers could better grasp the real-life context around observable health system events and the current concerns of an activated community. Engagement strengthened the research questions, methods, and interpretation of results and stimulated new lines of inquiry. In research that emphasizes electronic data sources, with no direct patient contact, the addition of patient voices is especially valuable. Patient voices are also especially needed in research on a stigmatized condition like bipolar disorder—to boost empathy and correct preconceptions. Further, simply incorporating periodic communication with external parties added value to our project; it enforced deliberate self-checks on our progress and improved communication within the team.

For those in DBSA, engaging in our project was an opportunity to be heard and shape the outside narrative about their community, learn and participate in research practice, and teach about advocacy practice. An often-overlooked aspect of recovery is the empowerment that one receives through amplification of one’s own voice or that of one’s community—especially for stigmatizing conditions. Knowing that researchers are invested in understanding the peer perspective beyond data analytics supports this key component of wellness for many individuals. The DBSA national organization benefited from acquiring skills outside of its areas of core competency. Its engagement created awareness about the power of research to bring about systemic change and positioned DBSA to capitalize on future research opportunities.

Ideally, our engagement between academics and peers would have begun earlier. The claims-based study design was largely determined in advance, building on previous studies focused on other health conditions. The quantitative design also had less inherent flexibility because of the limited set of available measures. Stakeholder engagement was a major force, however, shaping our qualitative study protocol. Another limitation of our engagement may have been heavy reliance on a single national partner organization. This approach was practical but potentially limited the scope of additional perspectives and may not have fully represented peers with bipolar disorder. The multiplicity of voices reaching us from that single organization tempered this concern somewhat. We appreciate that a fully participatory “co-production” approach (12, 15, 58, 59) to engagement would look different—it likely would involve larger numbers of patient representatives, including people from nonprofessional employer settings, in more phases and activities of the project, with more patient community control of project direction. We do not know what we may have missed by choosing a relatively pragmatic path for engagement.

The academic and advocacy worlds have different cultures and priorities yet share a desire for high-quality research results that may translate into future improvements in care. Our example shows how a complex, longitudinal, and flexible partnership can enhance research while respecting the distinct roles and needs of those involved. Embracing and including people experienced in living with or caring for someone living with a serious illness is an ethical and good-practice imperative for responsive research.

Department of Pharmacy and Health Systems Sciences, Northeastern University, Boston (Madden); Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston (Madden, Ross-Degnan, Callahan, Lu, Wharam); Depression and Bipolar Support Alliance, Chicago (Foxworth, Allen); McLean Hospital, Belmont, Massachusetts, and Department of Health Care Policy, Harvard Medical School, Boston (Busch).
Send correspondence to Dr. Madden ().

This research was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (HIS-1408-20393 to Dr. Wharam).

The statements in this publication are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors, or its Methodology Committee.

The authors report no financial relationships with commercial interests.

The authors thank the other members of their stakeholder advisor panel (Gregory E. Simon, M.D., M.P.H., Francisca Azocar, Ph.D., Denise D’Aunno, M.B.A., Kenneth Dolan-Del Vecchio, M.S.W., Kristin A. Olbertson, J.D., Ph.D., Ken Duckworth, M.D., and James Sabin, M.D.) for their continuous engagement with this study, and hundreds of members of the Depression and Bipolar Support Alliance online and advocacy community who supported this study with their experiences and insights. Additional research team members (Stephen B. Soumerai, Sc.D., Fang Zhang, Ph.D., Robert F. LeCates, M.A., Xin Xu, M.S., Carina Araujo-Lane, M.S.W., and Jamie Wallace, M.P.H., of Harvard Medical School and Harvard Pilgrim Health Care Institute) were essential to engagement efforts and project success.

References

1 Frank L, Basch E, Selby JV; Patient-Centered Outcomes Research Institute: The PCORI perspective on patient-centered outcomes research. JAMA 2014; 312:1513–1514Crossref, MedlineGoogle Scholar

2 Selby JV, Forsythe L, Sox HC: Stakeholder-driven comparative effectiveness research: an update from PCORI. JAMA 2015; 314:2235–2236Crossref, MedlineGoogle Scholar

3 Concannon TW, Fuster M, Saunders T, et al.: A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med 2014; 29:1692–1701Crossref, MedlineGoogle Scholar

4 Forsythe LP, Ellis LE, Edmundson L, et al.: Patient and stakeholder engagement in the PCORI pilot projects: description and lessons learned. J Gen Intern Med 2016; 31:13–21Crossref, MedlineGoogle Scholar

5 McDavitt B, Bogart LM, Mutchler MG, et al.: Dissemination as dialogue: building trust and sharing research findings through community engagement. Prev Chronic Dis 2016; 13:E38Crossref, MedlineGoogle Scholar

6 Witteman HO, Chipenda Dansokho S, Colquhoun H, et al.: Twelve lessons learned for effective research partnerships between patients, caregivers, clinicians, academic researchers, and other stakeholders. J Gen Intern Med 2018; 33:558–562Crossref, MedlineGoogle Scholar

7 Staley K, Kabir T, Szmukler G: Service users as collaborators in mental health research: less stick, more carrot. Psychol Med 2013; 43:1121–1125Crossref, MedlineGoogle Scholar

8 Forsythe L, Heckert A, Margolis MK, et al.: Methods and impact of engagement in research, from theory to practice and back again: early findings from the Patient-Centered Outcomes Research Institute. Qual Life Res 2018; 27:17–31Crossref, MedlineGoogle Scholar

9 Corrigan PW, Torres A, Lara JL, et al.: The healthcare needs of Latinos with serious mental illness and the potential of peer navigators. Adm Policy Ment Health Ment Health Serv Res 2017; 44:547–557Crossref, MedlineGoogle Scholar

10 Corrigan P, Sheehan L, Morris S, et al.: The impact of a peer navigator program in addressing the health needs of Latinos with serious mental illness. Psychiatr Serv 2018; 69:456–461LinkGoogle Scholar

11 Kogan JN, Schuster J, Nikolajski C, et al.: Challenges encountered in the conduct of optimal health: a patient-centered comparative effectiveness study of interventions for adults with serious mental illness. Clin Trials 2017; 14:5–16Crossref, MedlineGoogle Scholar

12 Michalak EE, Jones S, Lobban F, et al.: Harnessing the potential of community-based participatory research approaches in bipolar disorder. Int J Bipolar Disord 2016; 4:4Crossref, MedlineGoogle Scholar

13 Nestsiarovich A, Hurwitz NG, Nelson SJ, et al.: Systemic challenges in bipolar disorder management: a patient-centered approach. Bipolar Disord 2017; 19:676–688Crossref, MedlineGoogle Scholar

14 Rosenblat JD, Simon GE, Sachs GS, et al.: Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. J Affect Disord 2019; 243:116–120Crossref, MedlineGoogle Scholar

15 Israel BA, Schulz AJ, Parker EA, et al.: Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health 1998; 19:173–202Crossref, MedlineGoogle Scholar

16 Sheridan Rains L, Zenina T, Dias MC, et al.: Variations in patterns of involuntary hospitalisation and in legal frameworks: an international comparative study. Lancet Psychiatry 2019; 6:403–417Crossref, MedlineGoogle Scholar

17 Price A, Schroter S, Snow R, et al.: Frequency of reporting on patient and public involvement (PPI) in research studies published in a general medical journal: a descriptive study. BMJ Open 2018; 8:e020452Crossref, MedlineGoogle Scholar

18 Goldstrom ID, Campbell J, Rogers JA, et al.: National estimates for mental health mutual support groups, self-help organizations, and consumer-operated services. Adm Policy Ment Health Ment Health Serv Res 2006; 33:92–103Crossref, MedlineGoogle Scholar

19 Ostrow L, Penney D, Stuart E, et al.: Web-based survey data collection with peer support and advocacy organizations: implications of participatory methods. Prog Community Health Partnersh 2017; 11:45–52Crossref, MedlineGoogle Scholar

20 Ghisoni M, Wilson CA, Morgan K, et al.: Priority setting in research: user led mental health research. Res Involv Engagem 2017; 3:4Crossref, MedlineGoogle Scholar

21 Mann C, Chilcott S, Plumb K, et al.: Reporting and appraising the context, process and impact of PPI on contributors, researchers and the trial during a randomised controlled trial—the 3D study. Res Involv Engagem 2018; 4:15Crossref, MedlineGoogle Scholar

22 Likumahuwa-Ackman S, Angier H, Sumic A, et al.: IMPACCT Kids’ Care: a real-world example of stakeholder involvement in comparative effectiveness research. J Comp Eff Res 2015; 4:351–357Crossref, MedlineGoogle Scholar

23 Kilbourne AM, Neumann MS, Waxmonsky J, et al.: Public-academic partnerships: evidence-based implementation: the role of sustained community-based practice and research partnerships. Psychiatr Serv 2012; 63:205–207LinkGoogle Scholar

24 Walker ER, Zahn R, Druss BG: Applying a model of stakeholder engagement to a pragmatic trial for people with mental disorders. Psychiatr Serv 2018; 69:1127–1130LinkGoogle Scholar

25 Tai-Seale M, Sullivan G, Cheney A, et al.: The language of engagement: “aha!” moments from engaging patients and community partners in two pilot projects of the Patient-Centered Outcomes Research Institute. Perm J 2016; 20:89–92MedlineGoogle Scholar

26 Merkel PA, Manion M, Gopal-Srivastava R, et al.: Rare Diseases Clinical Research Network: The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis 2016; 11:66Crossref, MedlineGoogle Scholar

27 Kerner B, Crisanti AS, DeShaw JL, et al.: Preferences of information dissemination on treatment for bipolar disorder: patient-centered focus group study. JMIR Ment Health 2019; 6:e12848Crossref, MedlineGoogle Scholar

28 Smith SK, Selig W, Harker M, et al.: Patient engagement practices in clinical research among patient groups, industry, and academia in the united states: a survey. PLoS One 2015; 10:e0140232Crossref, MedlineGoogle Scholar

29 Fleurence RL, Beal AC, Sheridan SE, et al.: Patient-powered research networks aim to improve patient care and health research. Health Aff 2014; 33:1212–1219CrossrefGoogle Scholar

30 Sylvia LG, Hearing CM, Montana RE, et al.: MoodNetwork: an innovative approach to patient-centered research. Med Care 2018; 56(suppl 1):S48–S52Crossref, MedlineGoogle Scholar

31 Agiro A, Chen X, Eshete B, et al.: Data linkages between patient-powered research networks and health plans: a foundation for collaborative research. J Am Med Inform Assoc 2019; 26:594–602Crossref, MedlineGoogle Scholar

32 Wharam JF, Busch A, Madden JM, et al.: Effect of high-deductible insurance on mental health outpatient care in bipolar disorder. Am J Manag Care 2020; 26:248–255Crossref, MedlineGoogle Scholar

33 Madden JM, Araujo-Lane C, Foxworth P, et al.: Experiences of health care costs among people with employer-sponsored insurance and bipolar disorder. J Affect Disord. (Epub ahead of print, Oct 15, 2020)Google Scholar

34 Araujo-Lane C, Foxworth P, Ross-Degnan D, et al.: Accessing providers and coping with disruptions in employer-sponsored insurance: experiences of people with bipolar disorder. AcademyHealth Annual Research Meeting, 2018Google Scholar

35 Madden JM, Foxworth P, Busch AB, et al.: Impact of high cost-sharing on individuals with bipolar disorder in commercial plans and implications for pharmacy. American Pharmacists Association Annual Meeting, 2020Google Scholar

36 Lu CY, Busch AB, Zhang F, et al.: The impact of high-deductible health plans on medication use among individuals with bipolar disorder. Psychiatr Serv in pressGoogle Scholar

37 Hanson WE, Creswell JW, Clark VLP, et al.: Mixed methods research designs in counseling psychology. J Couns Psychol 2005; 52:224–235CrossrefGoogle Scholar

38 Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al.: Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994; 331:650–655Crossref, MedlineGoogle Scholar

39 Soumerai SB: Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Aff 2004; 23:135–146Crossref, MedlineGoogle Scholar

40 Busch AB, Frank RG, Lehman AF: The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia. Arch Gen Psychiatry 2004; 61:442–448Crossref, MedlineGoogle Scholar

41 Wharam JF, Landon BE, Galbraith AA, et al.: Emergency department use and subsequent hospitalizations among members of a high-deductible health plan. JAMA 2007; 297:1093–1102Crossref, MedlineGoogle Scholar

42 Lu CY, Soumerai SB, Ross-Degnan D, et al.: Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Med Care 2010; 48:4–9Crossref, MedlineGoogle Scholar

43 Lu CY, Adams AS, Ross-Degnan D, et al.: Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder. Psychiatr Serv 2011; 62:186–193LinkGoogle Scholar

44 Busch AB, Yoon F, Barry CL, et al.: The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. Am J Psychiatry 2013; 170:180–187LinkGoogle Scholar

45 Burns ME, Busch AB, Madden JM, et al.: Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries. Psychiatr Serv 2014; 65:323–329LinkGoogle Scholar

46 Madden JM, Adams AS, LeCates RF, et al.: Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D. JAMA Psychiatry 2015; 72:179–188Crossref, MedlineGoogle Scholar

47 Burns ME, Huskamp HA, Smith JC, et al.: The effects of the transition from Medicaid to Medicare on health care use for adults with mental illness. Med Care 2016; 54:868–877Crossref, MedlineGoogle Scholar

48 Busch AB, Huskamp HA, McWilliams JM: Early efforts by Medicare accountable care organizations have limited effect on mental illness care and management. Health Aff 2016; 35:1247–1256Crossref, MedlineGoogle Scholar

49 Wharam JF, Zhang F, Landon BE, et al.: Colorectal cancer screening in a nationwide high-deductible health plan before and after the Affordable Care Act. Med Care 2016; 54:466–473Crossref, MedlineGoogle Scholar

50 Wharam JF, Zhang F, Eggleston EM, et al.: Diabetes outpatient care and acute complications before and after high-deductible insurance enrollment: a natural experiment for translation in diabetes (NEXT-D) study. JAMA Intern Med 2017; 177:358–368Crossref, MedlineGoogle Scholar

51 Depression and Bipolar Support Alliance: DBSA. https://www.dbsalliance.org. Accessed April 24, 2020Google Scholar

52 Kelly JF, Hoffman L, Vilsaint C, et al.: Peer support for mood disorder: characteristics and benefits from attending the Depression and Bipolar Support Alliance mutual-help organization. J Affect Disord 2019; 255:127–135Crossref, MedlineGoogle Scholar

53 Care for Your Mind: CFYM. careforyourmind.org. Accessed Feb 24, 2020Google Scholar

54 Sheridan S, Schrandt S, Forsythe L, et al.: The PCORI engagement rubric: promising practices for partnering in research. Ann Fam Med 2017; 15:165–170Crossref, MedlineGoogle Scholar

55 Forsythe LP, Carman KL, Szydlowski V, et al.: Patient engagement in research: early findings from the Patient-Centered Outcomes Research Institute. Health Aff 2019; 38:359–367CrossrefGoogle Scholar

56 Harrison JD, Auerbach AD, Anderson W, et al.: Patient stakeholder engagement in research: a narrative review to describe foundational principles and best practice activities. Health Expect 2019; 22:307–316Crossref, MedlineGoogle Scholar

57 Goodman MS, Sanders Thompson VL: The science of stakeholder engagement in research: classification, implementation, and evaluation. Transl Behav Med 2017; 7:486–491Crossref, MedlineGoogle Scholar

58 Desai MU, Bellamy C, Guy K, et al.: “If you want to know about the book, ask the author”: enhancing community engagement through participatory research in clinical mental health settings. Behav Med 2019; 45:177–187Crossref, MedlineGoogle Scholar

59 Kalathil J, Jones N: Unsettling disciplines: madness, identity, research, knowledge. Phil Psychiatry Psychol 2016; 23:183–188CrossrefGoogle Scholar